Redeye retains its positive view on Transtema following a strong Q2 report. Both sales and margins beat our forecasts, and management’s outlook is positive. While the somewhat messy Q1 (due to EO and consolidations) put a lot of pressure on the share price, Q2 highlights the underlying business strength clearly, resulting in an, in our view, justified rally.
LÄS MER